If FDA approves for m2m and not s2c or vice versa, is this really still a win for both trials anyway since drs can prescribe the Lero as they see fit as long as it’s Coronavirus? Who’s going to determine when it’s severe vs moderate and say no, you can’t do that because it’s not bad enough yet or it’s too bad and it’s only for m2m? It’s very subjective, right? And who’s going to be policing the doctors that will want to give it to a moderate patient if it’s only approved for s2c? I think dr Fauci will be too busy to look over all those shoulders!